Missouri Investigates Companies Selling 7-OH Products
State officials are investigating nine distributors amid concerns that the substances pose opioid-like health risks.
Updated on Oct. 15, 2026 in Substance Abuse
Live Poll
Should the sale of 7-OH and similar chemical supplements be prohibited in your community?
Missouri Attorney General Catherine Hanaway has launched an investigation into nine companies involved in the sale of 7-OH products. The state is probing the manufacturing and distribution of these substances, which officials classify as dangerous drugs.
Why it matters
The investigation stems from concerns that 7-OH products pose health risks comparable to traditional opioids. State officials are working to better understand the availability and distribution of these substances across Missouri.
The Missouri Attorney General issued nine civil investigative demands to companies regarding their 7-OH operations. While the state characterizes these products as dangerous, the total market impact and the scope of these businesses remain under investigation.
The players
Catherine Hanaway
The Missouri Attorney General overseeing the state's legal investigation into 7-OH product distribution.
The details
7-OH, or 7-hydroxymitragynine, is the subject of this state inquiry due to its potential to cause adverse health outcomes. The Civil Investigative Demands require these companies to provide records on their manufacturing, distribution, and sales practices. This process allows the Attorney General to assess how these products reach the public and the extent of their footprint within the state.
Timeline
October 15, 2026: The Missouri Attorney General announced the investigation and issued demands to the companies.
Health Landscape
This investigation follows a broader national trend of state-level scrutiny regarding the sale of novel, potent substance products that mirror opioid effects. It marks an effort by Missouri to gain oversight of a market that has largely operated without traditional pharmaceutical-grade regulations.
If you or a family member have questions about the health risks associated with 7-OH products, consult your primary care physician to discuss potential opioid-like effects. It is important to stay informed about local public health advisories regarding substances that may cause dependency or other medical complications.
The takeaway
The state of Missouri has moved to investigate 7-OH distributors due to concerns over opioid-like health risks. Residents concerned about substances with similar chemical properties should discuss these risks directly with a doctor.
Further reading
For more information on how the state monitors public safety, visit our Substance Abuse section.
Live Poll
Should the sale of 7-OH and similar chemical supplements be prohibited in your community?
